Vir Biotechnology, Inc. - 8-K Filing

Vir Biotechnology enters underwriting agreement for $150 million public offering of 15 million shares of common stock (Items: 1.01 Entry into a Material Definitive Agreement, 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $VIR

Read the full article at SEC EDGAR

Part of the story Rezolute, Inc. - 8-K Filing (3 articles)

More Regulatory news